Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglei Cheng

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Computers in Biology and Medicine|November 29, 2023
A dual-population multi-objective evolutionary algorithm driven by generative adversarial networks for benchmarking and protein-peptide dockingHonglei Cheng, Gai-Ge Wang, Liyan Chen, et al.
Discover Oncology|October 30, 2024
Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in gliomaShenghua Zhuo, Shuo Yang, Shenbo Chen, et al.
Cancer Biomarkers : Section a of Disease Markers|November 19, 2013
Expression of PI3K, PTEN and Akt in small intestinal adenocarcinoma detected by quantum dots-based immunofluorescence technologyYi Zhang, Xue Yao, Congqing Jiang, et al.
CNS Neuroscience & Therapeutics|October 14, 2025
KIF4A Promotes Glioblastoma Malignant Progression and Transmission of Temozolomide Resistance in the Tumor Microenvironment via the HIF1A/VEGFA AxisXinan Shen, Honglei Cheng, Yihan Xia, et al.
Molecular Carcinogenesis|July 24, 2025
KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B/GPX4 Axis and Promotes Temozolomide ResistanceXinan Shen, Honglei Cheng, Jiarong Zheng, et al.
International Journal of Biological Macromolecules|November 27, 2025
TMEM165 promotes glioblastoma progression through epithelial-mesenchymal transition-mediated invasion and temozolomide chemoresistanceHonglei Cheng, Yueju Ding, Xinan Shen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Computers in Biology and Medicine|November 29, 2023
A dual-population multi-objective evolutionary algorithm driven by generative adversarial networks for benchmarking and protein-peptide dockingHonglei Cheng, Gai-Ge Wang, Liyan Chen, et al.
Discover Oncology|October 30, 2024
Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in gliomaShenghua Zhuo, Shuo Yang, Shenbo Chen, et al.
Cancer Biomarkers : Section a of Disease Markers|November 19, 2013
Expression of PI3K, PTEN and Akt in small intestinal adenocarcinoma detected by quantum dots-based immunofluorescence technologyYi Zhang, Xue Yao, Congqing Jiang, et al.
CNS Neuroscience & Therapeutics|October 14, 2025
KIF4A Promotes Glioblastoma Malignant Progression and Transmission of Temozolomide Resistance in the Tumor Microenvironment via the HIF1A/VEGFA AxisXinan Shen, Honglei Cheng, Yihan Xia, et al.
Molecular Carcinogenesis|July 24, 2025
KIF4A Inhibits Ferroptosis in Glioblastoma via the CHMP4B/GPX4 Axis and Promotes Temozolomide ResistanceXinan Shen, Honglei Cheng, Jiarong Zheng, et al.
International Journal of Biological Macromolecules|November 27, 2025
TMEM165 promotes glioblastoma progression through epithelial-mesenchymal transition-mediated invasion and temozolomide chemoresistanceHonglei Cheng, Yueju Ding, Xinan Shen, et al.
Pageof 1